Top News

Pfizer Submits COVID-19 Oral Antiviral Candidate to FDA for Emergency Use Authorization

November 17, 2021

Pfizer’s PAXLOVID oral solid-dosage treatment is designed to combat SARS-CoV-2 in high-risk patients at the first sign of infection.

Califf Named to Head FDA

November 12, 2021

The White House has nominated Robert Califf to head FDA, ending months of uncertainty about the future path for the high-profile agency.

FDA Grants EUA for Pfizer-BioNTech COVID-19 Vaccine Use in Children

November 01, 2021

The Pfizer-BioNTech COVID-19 vaccine is the first to receive FDA Emergency Use Authorization for use in children ages five to 11.

Moderna Announces Positive Results in Study On COVID-19 Vaccine in Children

October 26, 2021

Moderna’s KidCOVE study showed a robust neutralizing antibody response in children aged six to under 12.

Pfizer and BioNTech Release Phase III Trial Data Supporting Efficacy of Booster Doses

October 22, 2021

Pfizer and BioNTech’s Phase III trial demonstrated 95.6% booster efficacy relative to participants who received placebo.

FDA Amends EUA to Allow Booster Shots for Moderna, J&J COVID-19 Vaccines

October 21, 2021

In addition to allowing booster shots of the Moderna and J&J vaccines, FDA approved heterologous booster shots.

FDA Advisory Council Unanimously Supports Johnson & Johnson COVID-19 Booster EUA

October 19, 2021

The council voted 19-0 to recommend that FDA authorize booster doses of the J&J COVID-19 vaccine just one day after granting Moderna a similar recommendation.

FDA Advisory Council Unanimously Supports Moderna COVID-19 Booster EUA

October 15, 2021

The council voted 19–0 to recommend that FDA authorize booster doses of the Moderna COVID-19 vaccine for certain populations.

AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab

October 14, 2021

AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.

Pfizer, BioNTech Request EUA for COVID-19 Vaccine in Children Aged 5-11

October 08, 2021

Pfizer and BioNTech’s request would make them the first vaccine accessible to individuals under the age of 12.